Biotech Development

Biotech Development
Product Description

Accelerate your biotech innovation with Nordmark. 
As your reliable CDMO partner, we provide comprehensive end-to-end services—from early-stage process development and secure MCB/WCB production for both microbial and eukaryotic cells. Driven by a commitment to patient health, our cGMP-compliant manufacturing covers the entire lifecycle, supplying high-quality materials from clinical trials through to full commercialization. Combining decades of biomanufacturing expertise with state-of-the-art technologies, we seamlessly scale complex bioprocesses to help you deliver innovative therapies faster. Ready to bring your modern biologic to market? 


Contact our Business Development team today.

Read more Show less

Nordmark Pharma GmbH

  • Country/Region:
    Germany
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    500 - 999
Company types
Pharmaceutical company
Primary activities
API Producer
Natural Extracts
Pharmaceutical Company (innovator finished products)
View company profile
Categories
more categories Show less
Specifications
  • Details
    Specifications:
  • cGMP-compliant biomanufacturing from clinical development to full                           commercialization
  • Process development for both microbial and eukaryotic cell cultures
  • Secure Master Cell Bank (MCB) and Working Cell Bank (WCB) production
  • Advanced Upstream and Downstream Processing (USP/DSP) utilizing state-of-       the-art technologies
  • Seamless scale-up of complex bioprocesses
  • Comprehensive analytical testing and quality control

    •  Application Areas:
  • Innovative biopharmaceuticals and modern biological APIs
  • Manufacturing of materials for all clinical trial phases and commercial market           supply
  • Patient-centric therapies and advanced biologic treatments
  • Tech transfer and development partnering for biotech innovators and pharma            companies
  • Selling Points
    Experienced Technicians; International Approvals/Standards; Reputation
  • Model
    End-to-End Development & Manufacturing
  • Supplied from
    Germany
    • More specifications Fewer specifications
    Sales Markets
    Show more Show less

    Nordmark Pharma GmbH

    • Country/Region:
      Germany
    • On CPHI since:
      2015
    • Certificates:
      2
    • Employees:
      500 - 999
    Company types
    Pharmaceutical company
    Primary activities
    API Producer
    Natural Extracts
    Pharmaceutical Company (innovator finished products)
    View company profile

    More Products from Nordmark Pharma GmbH (8)

    • Pancreatin powder

      Product Pancreatin powder

      Nordmark Pharma GmbH provides a wide range of biological APIs which include pancreatin powder produced in Germany. It is differentiated by excellent free-flow properties and a high bulk density. The material can be used for direct compression tablet formulations. Diverse pancreatin powder product quali...
    • Enteric-coated Pancreatin pellets

      Product Enteric-coated Pancreatin pellets

      Nordmark Pharma GmbH provides a wide range of products based on our own produced biological APIs produced in Germany, which include enteric coated pancreatin pellets with high specific enzymatic activity and therefore patient-friendly capsule sizes. Diverse pellet product qualities according to custome...
    • Film-coated Pancreatin micro tablets

      Product Film-coated Pancreatin micro tablets

      Nordmark Pharma GmbH provides a wide range of drug products based on our own biological APIs produced in Germany, which include enteric-coated pancreatin micro tablets. Contrary to pellets, micro tablets are uniform in shape and the amount of active pharmaceutical ingredient of each tablet is exactly defin...
    • Collagenase NB

      Product Collagenase NB

      Apart from biological APIs Nordmark Pharma GmbH provides Collagenase NB derived from Clostridium histolyticum. Collagenase NB is a chromatographically purified mixture of enzymes used for tissue dissociation in-vitro and thus applicable for isolation of many different types of cells. The isolated cells ...
    • Collagenase N powder

      Product Collagenase N powder

      Nordmark Arzneimittel GmbH & Co. KG provides a wide range of biological APIs, including Collagenase N powder. Our collagenase is an enzyme preparation produced by fermentation using Clostridium histolyticum followed by purification and subsequent aseptic lyophilisation. At Nordmark, this asep...
    • Process and formulation development

      Product Process and formulation development

      Nordmark Arzneimittel GmbH & Co. KG provides a wide range of services such as process (fermentation and purification) and formulation development especially for biological drug substances/ products up to clinical phase III including special experience in microbiom formulation. Contact us for more i...
    • Pankreatan®

      Product Pankreatan®

      Nordmark Pharm GmbH provides finished drug products for the treatment of the gastrointestinal system, produced in Germany from our own API and designated for GI-treatment. This includes the brand Pankreatan®, pancreatin containing enteric coated micro tablets filled into capsules. Strengths: 10.000, 20....
    • Burlulipase

      Product Burlulipase

      Burlulipase is a pure, liquid, animal- and virus-free, highly active, and acid-stable lipase-only product from bacterial fermentation. This enzyme is tested in clinical trials with patients suffering from the failure or impairment of the pancreatic digestive function (exocrine pancreatic insufficiency, ...

    Nordmark Pharma GmbH resources (4)

    • Full Solution Provider for Microbial Fermentation

      Brochure Full Solution Provider for Microbial Fermentation

      Nordmark Biotech bundles all biotechnological activities ofNordmark. We are offering an all-in-one solution for microbialfermentation based products covering the entire value chain fromprocess development, analytics, production of API and finisheddrug product up to regulatory affairs and marketing authorisation.Our worldwide customers benefit from this integrated approach,which is based on solid project management, long-standing GMPexperience and recurrent EMA and FDA approvals.
    • Full Solution Provider for Animal Derived Extracts

      Datasheet Full Solution Provider for Animal Derived Extracts

      Nordmark Pharma is offering an all-in-one solution for animalderived extracts covering the entire value chain from processdevelopment, analytics, production of API and finished drug productup to regulatory affairs and marketing authorisation. Our worldwidecustomers benefit from this integrated approach, which is basedon solid project management, long-standing GMP experience,biosafety expertise and recurrent EMA and FDA approvals.
    • Full Solution Provider for Mammalian Cell Culture

      Brochure Full Solution Provider for Mammalian Cell Culture

      Nordmark Biotech bundles all biotechnological activities ofNordmark. We are offering an all-in-one solution for mammaliancell culture based products covering the entire value chain fromprocess development, analytics, production of API and finisheddrug product up to regulatory affairs and marketing authorisation.Our worldwide customers benefit from this integrated approach,which is based on solid project management, long-standing GMPexperience and recurrent EMA and FDA approvals.
    • Full Solution Provider for Live Biotherapeutics

      Datasheet Full Solution Provider for Live Biotherapeutics

      Nordmark Biotech bundles all biotechnological activities ofNordmark. We are offering an all-in-one solution for microbiomebased products covering the entire value chain from process development,analytics, production of drug substance (DS) and finisheddrug product (DP) up to regulatory affairs and marketing authorisation.Our worldwide customers benefit from this integrated approach,which is based on solid project management, long-standing GMPexpertise and recurrent EMA and FDA approvals.